Ulcerative Colitis
About The Study
Ulcerative colitis (UC) is a type of inflammatory bowel disease (IBD) characterized by diffuse, continuous inflammation of the colon. This disease affects people of all ages and recent estimates suggest that approximately 17,000 children between 5 and 17 years of age in the United States (US) are diagnosed with UC.
Ulcerative Colitis study is the treatment of mildly to moderately active ulcerative colitis (UC) in patients 5 years of age and older, and for the maintenance of remission of UC in pediatric subjects aged 5 to 17 years
Eligibility Criteria
- Pediatric male or female subject, ages 5 to 17 years at the time of the first dose of study drug.
- Diagnosis of Ulcerative Colitis (UC).
- No abnormal and clinically significant results according to the investigator or designee, on physical examination, medical history, ECG, hematology, clinical chemistry, or urinalysis.
- Bodyweight no less than 17 kg (37.5 lbs.) and no more than 90 kg (198lbs).
Contact Us for Unparalleled Clinical Research Solutions
Discover how our expertise and dedication can accelerate your research success